Published 2021 | Version v1
Journal article

Multi-scale optoacoustic molecular imaging of brain diseases

  • 1. Faculty of Medicine and Institute of Pharmacology and Toxicology, University of Zurich, Zurich (Switzerland)
  • 2. Zurich Neuroscience Center (ZNZ), Zurich (Switzerland)
  • 3. Institute for Biomedical Engineering, University of Zurich & ETH Zurich, Wolfgang-Pauli-Strasse 27, HIT E42.1, 8093, Zurich (Switzerland)
  • 4. Institute for Regenerative Medicine, Uiversity of Zurich, Zurich (Switzerland)

Description

The ability to non-invasively visualize endogenous chromophores and exogenous probes and sensors across the entire rodent brain with the high spatial and temporal resolution has empowered optoacoustic imaging modalities with unprecedented capacities for interrogating the brain under physiological and diseased conditions. This has rapidly transformed optoacoustic microscopy (OAM) and multi-spectral optoacoustic tomography (MSOT) into emerging research tools to study animal models of brain diseases. In this review, we describe the principles of optoacoustic imaging and showcase recent technical advances that enable high-resolution real-time brain observations in preclinical models. In addition, advanced molecular probe designs allow for efficient visualization of pathophysiological processes playing a central role in a variety of neurodegenerative diseases, brain tumors, and stroke. We describe outstanding challenges in optoacoustic imaging methodologies and propose a future outlook.

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00259-021-05207-4

Additional details

Identifiers

Publishing Information

Journal Title
European Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
48
Journal Issue
13
Journal Page Range
p. 4152-4170
ISSN
1619-7070
CODEN
EJNMA6

Optional Information

Notes
Oncology #En Dash# Digestive tract